19 - References

References
944
The Maudsley® Prescribing Guidelines in Psychiatry
CHAPTER 14
References
Olaisen RH, et  al. Assessing the longitudinal impact of physician-­patient relationship on functional health. Ann Fam Med 2020;
18:422–429.
McKay KM, et al. Psychiatrist effects in the psychopharmacological treatment of depression. J Affect Disord 2006; 92:287–290.
Kelley JM, et al. The influence of the patient-­clinician relationship on healthcare outcomes: a systematic review and meta-­analysis of randomized controlled trials. PLoS One 2014; 9:e94207.
Ridd M, et  al. The patient-­doctor relationship: a synthesis of the qualitative literature on patients’ perspectives. Br J Gen Pract 2009;
59:e116–e133.
Bargh JA, et al. The unbearable automaticity of being. Am Psychol 1999; 54:462.
Mintz DL, et  al. How (not what) to prescribe: nonpharmacologic aspects of psychopharmacology. Psychiatr Clin North Am 2012;
35:143–163.
Konstantinidou H, et al. Will this tablet make me happy again? The contribution of relational prescribing in providing a pragmatic and
psychodynamic framework for prescribers. BJPsych Advances 2023; 29:265–273.
Ravindran N, et al. Cultural influences on perceptions of health, illness, and disability: a review and focus on autism. J Child Fam Studies
2012; 21:311–319.
Lam WY, et al. Medication adherence measures: an overview. BioMed Res Int 2015; 2015:217047.
Brooks LA, et al. Culturally sensitive communication in healthcare: a concept analysis. Collegian 2019; 26:383–391.
Beitman BD, et al. Patient stage of change predicts outcome in a panic disorder medication trial. Anxiety 1994; 1:64–69.
Prochaska JO, et al. Stages and processes of self-­change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;
51:390–395.
Roughley M, et al. Referral of patients with emotionally unstable personality disorder for specialist psychological therapy: why, when and
how? BJPsych Bull 2021; 45:52–58.
Gibbons R. The mourning process and its importance in mental illness: a psychoanalytic understanding of psychiatric diagnosis and classification. BJPsych Advances 2024; 30:80–88.
Lee T, et al. Managing the clinical encounter with patients with personality disorder in a general psychiatry setting: key contributions from
neuropsychoanalysis. BJPsych Advances 2023; doi:10.1192/bja.2023.43.
Finniss DG, et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375:686–695.
Piguet V, et al. Patients’ representations of antidepressants: a clue to nonadherence? Clin J Pain 2007; 23:669–675.
Bull SA, et  al. Discontinuation of use and switching of antidepressants: influence of patient-­physician communication. JAMA 2002;
288:1403–1409.
Benedetti F. Placebo and the new physiology of the doctor-­patient relationship. Physiol Rev 2013; 93:1207–1246.
Data-­Franco J, et al. The nocebo effect: a clinicians guide. Aust NZ J Psychiatry 2013; 47:617–623.
Adshead G. Psychiatric staff as attachment figures. Understanding management problems in psychiatric services in the light of attachment
theory. Br J Psychiatry 1998; 172:64–69.
Ciechanowski PS, et al. The patient-­provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry 2001;
158:29–35.
Ciechanowski PS, et al. The association of patient relationship style and outcomes in collaborative care treatment for depression in patients
with diabetes. Med Care 2006; 44:283–291.
Mintz D. Psychodynamic Psychopharmacology: Caring for the Treatment-­Resistant Patient. Washington, DC: American Psychiatric
Association Publishing; 2022.
Lin P, et al. The influence of patient preference on depression treatment in primary care. Ann Behav Med 2005; 30:164–173.
Kocsis JH, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive
behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009; 70:354–361.